arrow
Back
N

Nn Blokhin Natl Med Res Ctr Oncol

Scholars25
Papers13
Citations4
Related Papers (11)
Publication Date
Secosteroid-1,3,4-oxadiazole hybrids: Synthesis and evaluation of their activity against hormone-dependent breast cancer cells
err2025-07-01
err0
PREAI
errIlovaisky, Alexey I.; Scherbakov, Alexander M.; Miciurov, Dumitru; Chernoburova, Elena I.; Merkulova, Valentina M.; Bogdanov, Fedor B.; Salnikova, Diana I.; Sorokin, Danila, V; Krasil'nikov, Mikhail A.; Bozhenko, Eugene I.; Zavarzin, Igor, V; Terent'ev, Alexander O.
errShare
errSave
AIE-active Cyclen-BODIPYs as multiresponsive fluorescent probes for imaging in biological samples: Design and comprehensive study
errTALANTA
IF6.1
err2025-05-17
err0
PREAI
errUvarov, Denis Y.; Sapoletova, Nina A.; Kushnir, Sergey E.; Selektor, Sofiya L.; Golovanov, Ivan S.; Chursin, Anatoly Y.; Scherbakov, Alexander M.; Salnikova, Diana I.; Kopnin, Pavel B.; Kolotyrkina, Natalya G.; Fakhrutdinov, Artem; Malakhova, Victoria; Sibgatullina, Guzel; Samigullin, Dmitry; Zavarzin, Igor, V; Goze, Christine; Denat, Franck; Volkova, Yulia A.
errShare
errSave
Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder Study
err2025-02-14
err0
errOAAI
errTsimafeyeu, Ilya; Gridneva, Yana; Sultanbaev, Alexander; Anzhiganova, Yulia; Gluzman, Mark; Mochalova, Anastasia; Shkurat, Alexey; Israelyan, Edgar; Parsadanova, Elvira; Murzina, Yulia; Ivanov, Aleksei; Kalpinskiy, Alexey; Stativko, Olesia; Petkau, Vladislav; Karabina, Elena; Keln, Artyom; Tovbik, Natalya; Safina, Sufia; Turganova, Maria; Kopyltsov, Evgeny; Bragina, Varvara; Novikova, Olga; Lebedinets, Andrei; Vodolazskiy, Vladislav; Rumyantsev, Alexey; Zukov, Ruslan; Pokataev, Ilya; Orlova, Rashida; Volkova, Maria
errShare
errSave
Ultrasmall maghemite nanoparticles as MRI contrast agent: Unique combination of aggregation stability, low toxicity, and tumor visualization
err2025-02-01
err0
PREAI
errMoiseeva, Ekaterina O.; Skribitsky, Vsevolod A.; Finogenova, Yulia A.; German, Sergei V.; Shpakova, Kristina E.; Sergeev, Igor S.; Terentyeva, Daria A.; Sindeeva, Olga A.; Kulikov, Oleg A.; Lipengolts, Alexey A.; Grigorieva, Elena Yu.; Gorin, Dmitry A.
errShare
errSave
Synthesis of New Promising BNCT Agents Based on Conjugates of closo-Dodecaborate Anion and Aliphatic Diamino Acids
err2024-12-25
err1
errOAAI
errRyabchikova, Margarita N.; Nelyubin, Alexey V.; Klyukin, Ilya N.; Selivanov, Nikita A.; Bykov, Alexander Yu.; Kubasov, Alexey S.; Skribitsky, Vsevolod A.; Finogenova, Yulia A.; Shpakova, Kristina E.; Kasianov, Anton A.; Lipengolts, Alexey A.; Zhdanov, Andrey P.; Grigoreva, Elena Yu.; Zhizhin, Konstantin Yu.; Kuznetsov, Nikolay T.
errShare
errSave
Impact of baseline tumour burden on outcomes in EMERALD-1: A phase III study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
err2024-12-01
err1
PREAI
errKudo, M.; Lencioni, R.; Erinjeri, J.; Chan, S. L.; Qin, S.; Ren, Z.; Arai, Y.; Heo, J.; Breder, V. V.; Bouattour, M.; Dayyani, F.; Yoon, J-H.; Chiu, C-F.; Suttichaimongkol, T.; Decaens, T.; Griffin, R.; Morgan, C.; Ali, S. K.; Balaji, K.; Sangro, B.
errShare
errSave
Five-year overall survival (OS) and OS by baseline liver function from the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
err2024-12-01
err1
PREAI
errKudo, M.; Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Breder, V. V.; Varela, M.; Crysler, O. V.; Bouattour, M.; Dao, V. T.; Faccio, A.; Furuse, J.; Jeng, L-B.; Kang, Y-K.; Kelley, R. K.; Paskow, M. J.; Makowsky, M.; Ran, D.; Negro, A.; Abou-Alfa, G. K.
errShare
errSave
A multicenter randomized clinical trial evaluating the negative hyperselection of patients with RAS/BRAF wild-type metastatic colorectal cancer who are eligible for anti-EGFR therapy
err2024-09-01
err0
PREAI
errPokataev, I.; Tryakin, A.; Fedyanin, M.; Antonova, T.; Semenova, A.; Lebedeva, A.; Kuznetsova, O. A.; Veselovsky, E.; Ivanov, M.; Mileyko, V.; Byakhov, M.; Biakhova, M.; Galkin, V.
errShare
errSave
Outcomes by baseline tumour burden in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in participants (pts) with embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
err2024-09-01
err0
PREAI
errKudo, M.; Lencioni, R.; Erinjeri, J. P.; Chan, S. L.; Qin, S.; Ren, Z.; Arai, Y.; Heo, J.; Breder, V.; Bouattour, M.; Dayyani, F.; Yoon, J-H.; Chiu, C-F.; Suttichaimongkol, T.; Decaens, T.; Griffin, R.; Morgan, C.; Ali, S. K.; Balaji, K.; Sangro, B.
errShare
errSave
Long-term survival with neoadjuvant therapy in melanoma: Updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
err2024-09-01
err5
PREAI
errLong, G. V.; Blank, C. U.; Amaria, R. N.; Hieken, T. J.; Sandhu, S. K.; Barros, M. J.; Mitchell, T. C. C.; Eroglu, Z.; Samoylenko, I. V.; Rutkowski, P.; Johnson, D.; da Silva, I. Pires; Perry, K. A.; Tawbi, H. A.; Block, M. S.; Ascierto, P. A.; Burton, E.; van Akkooi, A. C. J.; Scolyer, R. A.; Menzies, A. M.
errShare
errSave
DEFENDOR special: Real-world use of pegylated granulocyte-colony stimulating factor in patients with gastrointestinal cancers
err2024-09-01
err0
PREAI
errTryakin, A.; Dinaeva, E.; Fedyanin, M.; Margusheva, A.; Avdyukhin, I.; Prosianikova, O.; Sorokina, I.
errShare
errSave